ciprofloxacin has been researched along with Sensitivity and Specificity in 160 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The suitability of the 18F-labelled fluoroquinolone antibiotic ciprofloxacin ([18F]ciprofloxacin) for imaging of bacterial infections with positron emission tomography (PET) was assessed in vitro and in vivo." | 9.11 | In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. ( Brunner, M; Dobrozemsky, G; Dudczak, R; Joukhadar, C; Kletter, K; Lackner, E; Langer, O; Minar, E; Mitterhauser, M; Müller, M; Müller, U; Wadsak, W; Zeitlinger, M; Ziegler, S, 2005) |
| "99mTc-ciprofloxacin is a radiopharmaceutical preparation sintetized to improve diagnostic accuracy of bacterial infections in human tissues." | 7.75 | Estimation of 99mTc-ciprofloxacin accumulation indexes in bone and joint bacterial infections. ( Dugonjić, S; Janković, Z; Popović, Z; Pucar, D, 2009) |
| "To evaluate the efficacy of a new nuclear imaging Infecton (Tc-99m ciprofloxacin) for the diagnosis of acute cholecystitis." | 7.74 | Tc-99m ciprofloxacin imaging in acute cholecystitis. ( Ahn, SI; Cho, YU; Choe, W; Choe, YM; Choi, SK; Hong, KC; Hur, YS; Kim, K; Kim, KR; Kim, SJ; Lee, KY; Shin, SH; Woo, ZH, 2007) |
| "Ciprofloxacin and IS were eluted on a Synergi Max-RP analytical column (150 mm×4." | 5.37 | Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. ( Karisa, J; Kokwaro, GO; Maitland, K; Muchohi, SN; Muturi, A; Thuo, N, 2011) |
| "Brucellosis is a disease of domestic and wild animals that is transmitted to humans and exists worldwide." | 5.32 | Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. ( Cardeñosa, O; Contreras-Rodríguez, A; Gutiérrez-Rubio, AT; Hernández-Oliva, GM; López-Merino, A; Migranas-Ortiz, R; Orrantia-Gradín, R, 2004) |
| "Typhi strains from patients with typhoid fever seen at our center in 1995 (median MIC 0." | 5.32 | Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. ( Abraham, OC; Jesudason, MV; John, TJ; Mathai, D; Rupali, P; Sivaram, S; Zachariah, A, 2004) |
| "The suitability of the 18F-labelled fluoroquinolone antibiotic ciprofloxacin ([18F]ciprofloxacin) for imaging of bacterial infections with positron emission tomography (PET) was assessed in vitro and in vivo." | 5.11 | In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. ( Brunner, M; Dobrozemsky, G; Dudczak, R; Joukhadar, C; Kletter, K; Lackner, E; Langer, O; Minar, E; Mitterhauser, M; Müller, M; Müller, U; Wadsak, W; Zeitlinger, M; Ziegler, S, 2005) |
| "To determine the sensitivity and specificity of 99mTc-Infecton (Infecton), a novel ciprofloxacin based imaging agent, in detecting sites of infection." | 5.08 | Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection. ( Britton, KE; Das, SS; Hall, AV; Solanki, KK; Vinjamuri, S, 1998) |
| "In the present study, sensitivity and specificity of the phage assay when compared to proportion method were in the range of 97 to 100 per cent for all the drugs except for ciprofloxacin for which it was 93 and 96 per cent, respectively." | 3.78 | In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates. ( Chitnis, DS; Hemvani, N; Patidar, V, 2012) |
| "99mTc-ciprofloxacin is a radiopharmaceutical preparation sintetized to improve diagnostic accuracy of bacterial infections in human tissues." | 3.75 | Estimation of 99mTc-ciprofloxacin accumulation indexes in bone and joint bacterial infections. ( Dugonjić, S; Janković, Z; Popović, Z; Pucar, D, 2009) |
| "To evaluate the efficacy of a new nuclear imaging Infecton (Tc-99m ciprofloxacin) for the diagnosis of acute cholecystitis." | 3.74 | Tc-99m ciprofloxacin imaging in acute cholecystitis. ( Ahn, SI; Cho, YU; Choe, W; Choe, YM; Choi, SK; Hong, KC; Hur, YS; Kim, K; Kim, KR; Kim, SJ; Lee, KY; Shin, SH; Woo, ZH, 2007) |
| "The aim of the present study was to characterize the population pharmacokinetics of ciprofloxacin in patients with and without cystic fibrosis ranging in age from 1 day to 24 years and to propose a limited sampling strategy to estimate individual pharmacokinetic parameters." | 3.72 | Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections. ( Aigrain, Y; Aujard, Y; Bressolle, F; Jacqz-Aigrain, E; Munck, A; Payen, S; Serreau, R, 2003) |
| "Comparative susceptibility of microflora isolates from patients with complicated urinary tract infections to cefepime, other cephalosporins, amikacin, ciprofloxacin and ofloxacin was studied." | 3.72 | [Cefepime (maxipime) in the treatment of severe urinary tract infection]. ( Derevianko, II, 2003) |
| "The aim of the study was to distinguish infection from inflammation in patients with suspected infection using technetium-99m Infecton." | 3.69 | Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. ( Bomanji, J; Britton, KE; Das, S; Hall, AV; Siraj, QH; Solanki, K; Vinjamuri, S, 1997) |
| " The method reported in this study can be implemented for pharmacokinetic interaction study in rats." | 1.62 | Simultaneous HPLC Assay of Gliclazide and Ciprofloxacin in Plasma and its Implementation for Pharmacokinetic Study in Rats. ( Adiwidjaja, J; Leo, M; Pratiwi, GK; Sasongko, L, 2021) |
| "All ciprofloxacin DST results were susceptible by both methods." | 1.56 | MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia. ( Balada-Llasat, JM; Evans, CA; Gelaw, B; Kelley, HV; Shibabaw, A; Tesfaye, E; Tessema, B; Torrelles, JB; Wang, SH, 2020) |
| "Ciprofloxacin has been the most widely prescribed one which exhibits good activity against Pseudomonas aeruginosa and Acinetobacter." | 1.51 | Development of a new liquid chromatographic method for the simultaneous separation of ciprofloxacin degradation products with 5-hydroxymethyl-furfural, impurity of D-glucose, in an intravenous solution for perfusion. ( Louati, K; Mlouka, M; Safta, F, 2019) |
| "Ciprofloxacin was separated on a C18 column eluted with a mobile phase constituted of a mixture of 0." | 1.43 | Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats. ( Dalla Costa, T; Torres, BG; Zimmermann, ES, 2016) |
| "Ciprofloxacin and IS were eluted on a Synergi Max-RP analytical column (150 mm×4." | 1.37 | Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. ( Karisa, J; Kokwaro, GO; Maitland, K; Muchohi, SN; Muturi, A; Thuo, N, 2011) |
| "Enrofloxacin (ENR) is a fluoroquinolone developed exclusively for the use in veterinary practice for the treatment of respiratory and gastrointestinal infections, and ciprofloxacin (CIP) is its main active metabolite." | 1.35 | Development and application of a capillary electrophoresis-electrochemiluminescent method for the analysis of enrofloxacin and its metabolite ciprofloxacin in milk. ( Jia, L; Tang, Y; Xing, D; Zhou, X; Zhu, D, 2008) |
| "ciprofloxacin, in eggs was conducted." | 1.35 | Simple assay for monitoring seven quinolone antibacterials in eggs: extraction with hot water and liquid chromatography coupled to tandem mass spectrometry. Laboratory validation in line with the European Union Commission Decision 657/2002/EC. ( Bogialli, S; D'Ascenzo, G; Di Corcia, A; Laganà, A; Tramontana, G, 2009) |
| " This method was successfully applied in the pharmacokinetic studies in rats." | 1.34 | Determination of caderofloxacin lactate in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. ( Liang, Y; Liu, H; Liu, L; Liu, X; Pang, X; Xie, L; Xu, X; Zhang, D, 2007) |
| "Ciprofloxacin is a broad-spectrum antibiotic that has been used as a radiolabelled antibiotic in both the diagnosis of infections in rabbits and in clinical trials on humans." | 1.33 | Technetium-99m ciprofloxacin imaging in the diagnosis of postsurgical bony infection and evaluation of the response to antibiotic therapy: A case report. ( Aggarwal, A; Bhattacharya, A; Mittal, BR; Nagi, ON; Singh, AK; Singh, B, 2005) |
| "Brucellosis is a disease of domestic and wild animals that is transmitted to humans and exists worldwide." | 1.32 | Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. ( Cardeñosa, O; Contreras-Rodríguez, A; Gutiérrez-Rubio, AT; Hernández-Oliva, GM; López-Merino, A; Migranas-Ortiz, R; Orrantia-Gradín, R, 2004) |
| "The proportion of patients with influenza in the community affected the choice of strategy, so that seasonal variation exists." | 1.32 | Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. ( Fine, AM; Fleisher, GR; Fraser, HS; Mandl, KD; Wong, JB, 2004) |
| "Typhi strains from patients with typhoid fever seen at our center in 1995 (median MIC 0." | 1.32 | Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. ( Abraham, OC; Jesudason, MV; John, TJ; Mathai, D; Rupali, P; Sivaram, S; Zachariah, A, 2004) |
| " Ceftazidime plus ciprofloxacin and ceftazidime plus tobramycin were dosed every 12 h for 48 h using simultaneous or staggered administration." | 1.32 | Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model. ( Ariano, RE; Harding, GK; Iacovides, H; Zelenitsky, SA, 2004) |
| "Levofloxacin was dosed at 0 and 24 h, elimination pharmacokinetics were simulated, and viable counts were measured over 30 h." | 1.31 | Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. ( Lister, PD, 2002) |
| "Garenoxacin was the most active agent overall against Gram-positive organisms, with potent activity against Aerococcus spp." | 1.31 | Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients. ( Frisbee-Hume, S; Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H, 2002) |
| "Gatifloxacin is an advanced-generation, 8-methoxyfluoroquinolone that is active against a broad spectrum of pathogens, including antiobiotic resistant Streptococcus pneumoniae." | 1.31 | Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry. ( Bartlett, MG; Stewart, JT; Vishwanathan, K, 2001) |
| "Trovafloxacin was very active against gonococci (MIC90, 0." | 1.30 | Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results. ( Barrett, MS; Deguchi, T; Jones, RN, 1997) |
| " The suitability of the assay for pharmacokinetic studies was determined by measuring enrofloxacin and ciprofloxacin concentrations either in pig plasma after administration of a single intravenous 5 mg/kg dose of enrofloxacin or in rabbit plasma and TCF during a 24 h infusion of enrofloxacin at a rate of 1." | 1.30 | Simultaneous determination of enrofloxacin and ciprofloxacin in animal biological fluids by high-performance liquid chromatography. Application in pharmacokinetic studies in pig and rabbit. ( Gicquel, M; Laurentie, M; Manceau, J; Sanders, P, 1999) |
| "The clinafloxacin spectrum was widest against these resistant isolates, and the other two tested fluoroquinolones (ciprofloxacin, fleroxacin) possessed comparable overall spectrums of activity, although ciprofloxacin was generally more active on a weight basis." | 1.29 | Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates. ( Johnson, DM; Jones, RN, 1995) |
| "We used this agent to image bacterial infection in 56 patients (one twice) with known or suspected sites of infection." | 1.29 | Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. ( Bomanji, J; Britton, KE; Das, SS; Hall, AV; O'Shaughnessy, E; Siraj, Q; Solanki, KK; Vinjamuri, S, 1996) |
| " The time course of ENR and CIP was fitted by nonlinear least squares regression analysis, and the pharmacokinetic variables were compared." | 1.29 | Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. ( Abadía, AR; Aramayona, JJ; Bregante, MA; Fraile, LJ; García, MA; Mora, J, 1996) |
| "To determine the changing spectrum of typhoid fever, a study was conducted on 240 cases of typhoid fever, admitted over a period of 4 years." | 1.29 | Changing spectrum of typhoid. ( Durrani, AB; Rab, SM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 31 (19.38) | 18.2507 |
| 2000's | 93 (58.13) | 29.6817 |
| 2010's | 32 (20.00) | 24.3611 |
| 2020's | 4 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lanyero, H | 1 |
| Ocan, M | 1 |
| Obua, C | 1 |
| Stålsby Lundborg, C | 1 |
| Agaba, K | 1 |
| Kalyango, JN | 1 |
| Eriksen, J | 1 |
| Nanzigu, S | 1 |
| Shibabaw, A | 1 |
| Gelaw, B | 1 |
| Kelley, HV | 1 |
| Tesfaye, E | 1 |
| Balada-Llasat, JM | 1 |
| Evans, CA | 2 |
| Torrelles, JB | 1 |
| Wang, SH | 1 |
| Tessema, B | 1 |
| de Korne-Elenbaas, J | 1 |
| Pol, A | 1 |
| Vet, J | 1 |
| Dierdorp, M | 1 |
| van Dam, AP | 1 |
| Bruisten, SM | 1 |
| Sasongko, L | 1 |
| Pratiwi, GK | 1 |
| Leo, M | 1 |
| Adiwidjaja, J | 1 |
| Peris-Vicente, J | 1 |
| Tayeb-Cherif, K | 1 |
| Carda-Broch, S | 1 |
| Esteve-Romero, J | 1 |
| Perera, SR | 1 |
| Khan, NH | 1 |
| Martin, I | 3 |
| Taheri, A | 1 |
| Parti, RP | 1 |
| Levett, PN | 1 |
| Horsman, GB | 1 |
| Kusalik, A | 1 |
| Dillon, JR | 1 |
| Maxson, T | 1 |
| Taylor-Howell, CL | 1 |
| Minogue, TD | 1 |
| Peterson, SW | 2 |
| Demczuk, W | 2 |
| Hoang, L | 2 |
| Wylie, J | 2 |
| Lefebvre, B | 2 |
| Labbé, AC | 1 |
| Naidu, P | 1 |
| Haldane, D | 2 |
| Mulvey, MR | 2 |
| Jönsson, A | 1 |
| Jacobsson, S | 1 |
| Foerster, S | 1 |
| Cole, MJ | 1 |
| Unemo, M | 2 |
| Louati, K | 1 |
| Mlouka, M | 1 |
| Safta, F | 1 |
| Ebeyan, S | 1 |
| Windsor, M | 1 |
| Bordin, A | 1 |
| Mhango, L | 1 |
| Erskine, S | 1 |
| Trembizki, E | 1 |
| Mokany, E | 1 |
| Tan, LY | 1 |
| Whiley, D | 1 |
| Kirkcaldy, RD | 1 |
| Zaidi, A | 1 |
| Hook, EW | 1 |
| Holmes, KK | 1 |
| Holmes, KH | 1 |
| Soge, O | 1 |
| del Rio, C | 1 |
| Hall, G | 1 |
| Papp, J | 1 |
| Bolan, G | 1 |
| Weinstock, HS | 1 |
| Orlando, RM | 1 |
| Rath, S | 2 |
| Rohwedder, JJ | 1 |
| Mohan, S | 1 |
| Oluwafemi, OS | 1 |
| George, SC | 1 |
| Jayachandran, VP | 1 |
| Lewu, FB | 1 |
| Songca, SP | 1 |
| Kalarikkal, N | 1 |
| Thomas, S | 1 |
| Zimmermann, ES | 1 |
| Torres, BG | 1 |
| Dalla Costa, T | 1 |
| Bharat, A | 1 |
| Allen, V | 1 |
| Tyrrell, G | 1 |
| Horsman, G | 1 |
| Garceau, R | 1 |
| Wong, T | 1 |
| Rodríguez-Martínez, JM | 1 |
| Santiso, R | 2 |
| Machuca, J | 1 |
| Bou, G | 2 |
| Pascual, Á | 1 |
| Fernández, JL | 2 |
| Dhodapkar, R | 1 |
| Kumar, A | 1 |
| Zhou, X | 1 |
| Xing, D | 1 |
| Zhu, D | 1 |
| Tang, Y | 1 |
| Jia, L | 1 |
| Wu, SS | 1 |
| Chein, CY | 1 |
| Wen, YH | 1 |
| Zorita, S | 1 |
| Larsson, L | 1 |
| Mathiasson, L | 1 |
| Yan, H | 1 |
| Tian, M | 1 |
| Row, KH | 1 |
| Liu, YM | 1 |
| Jia, YX | 1 |
| Tian, W | 1 |
| Love, C | 1 |
| Marwin, SE | 1 |
| Palestro, CJ | 1 |
| Bogialli, S | 1 |
| D'Ascenzo, G | 1 |
| Di Corcia, A | 1 |
| Laganà, A | 1 |
| Tramontana, G | 1 |
| Neumann, MB | 1 |
| Gujer, W | 1 |
| von Gunten, U | 1 |
| Pucar, D | 1 |
| Janković, Z | 1 |
| Dugonjić, S | 1 |
| Popović, Z | 1 |
| Paschoal, JA | 1 |
| Reyes, FG | 1 |
| Tamayo, M | 1 |
| del Carmen Fernández, M | 1 |
| Molina, F | 1 |
| Villanueva, R | 1 |
| Gosálvez, J | 1 |
| Watabe, S | 1 |
| Yokoyama, Y | 1 |
| Nakazawa, K | 1 |
| Shinozaki, K | 1 |
| Hiraoka, R | 1 |
| Takeshita, K | 1 |
| Suzuki, Y | 1 |
| Husain, EH | 1 |
| Dashti, AA | 1 |
| Electricwala, QY | 1 |
| Abdulsamad, AM | 1 |
| Al-Sayegh, S | 1 |
| Choi, JH | 1 |
| Na, TW | 1 |
| Mamun, MI | 1 |
| Abd El-Aty, AM | 2 |
| Shin, EH | 1 |
| Park, JH | 1 |
| Shim, JH | 2 |
| Sousa, J | 1 |
| Alves, G | 1 |
| Fortuna, A | 1 |
| Pena, A | 1 |
| Lino, C | 1 |
| Falcão, A | 1 |
| Aranda, A | 1 |
| Mayorga, C | 1 |
| Ariza, A | 1 |
| Doña, I | 1 |
| Rosado, A | 1 |
| Blanca-Lopez, N | 1 |
| Andreu, I | 1 |
| Torres, MJ | 1 |
| Grondin, C | 1 |
| Zhao, W | 1 |
| Fakhoury, M | 1 |
| Jacqz-Aigrain, E | 2 |
| Fuster, D | 1 |
| Soriano, A | 1 |
| Garcia, S | 1 |
| Piera, C | 1 |
| Suades, J | 1 |
| Rodríguez, D | 1 |
| Martinez, JC | 1 |
| Mensa, J | 2 |
| Campos, F | 1 |
| Pons, F | 1 |
| Muchohi, SN | 1 |
| Thuo, N | 1 |
| Karisa, J | 1 |
| Muturi, A | 1 |
| Kokwaro, GO | 1 |
| Maitland, K | 1 |
| Lombardo-Agüí, M | 1 |
| Gámiz-Gracia, L | 1 |
| Cruces-Blanco, C | 1 |
| García-Campaña, AM | 1 |
| Mahrouse, MA | 1 |
| Elkady, EF | 1 |
| Hemvani, N | 2 |
| Patidar, V | 2 |
| Chitnis, DS | 2 |
| Acharya, D | 1 |
| Trakulsomboon, S | 1 |
| Madhup, SK | 1 |
| Korbsrisate, S | 1 |
| Toit, K | 1 |
| Mitchell, S | 1 |
| Balabanova, Y | 1 |
| Kummik, T | 1 |
| Nikolayevskyy, V | 1 |
| Drobniewski, F | 1 |
| Fussell, RJ | 1 |
| Heinrich, K | 1 |
| Dickinson, M | 1 |
| Wilkins, S | 1 |
| Roelofs, V | 1 |
| Murray, A | 1 |
| Kay, JF | 1 |
| Sharman, M | 1 |
| Olson, RP | 1 |
| Haith, K | 1 |
| Liss, MA | 1 |
| Nakamura, KK | 1 |
| Peterson, EM | 1 |
| Balashov, S | 1 |
| Mordechai, E | 1 |
| Adelson, ME | 1 |
| Gygax, SE | 1 |
| Deitmer, T | 1 |
| Carattoli, A | 1 |
| Dionisi, A | 1 |
| Luzzi, I | 1 |
| Horstkötter, C | 1 |
| Jiménez-Lozano, E | 2 |
| Barrón, D | 2 |
| Barbosa, J | 2 |
| Blaschke, G | 2 |
| Sieper, J | 1 |
| Braun, J | 1 |
| Burgess, DS | 1 |
| Nathisuwan, S | 1 |
| Lister, PD | 1 |
| Pendland, SL | 1 |
| Neuhauser, MM | 1 |
| Garey, KW | 1 |
| Prause, JL | 1 |
| Jung, R | 1 |
| Posyniak, A | 2 |
| Zmudzki, J | 2 |
| Niedzielska, J | 2 |
| Golet, EM | 1 |
| Strehler, A | 1 |
| Alder, AC | 1 |
| Giger, W | 1 |
| Rolston, KV | 1 |
| Frisbee-Hume, S | 1 |
| LeBlanc, BM | 1 |
| Streeter, H | 1 |
| Ho, DH | 1 |
| Manno, G | 1 |
| Ugolotti, E | 1 |
| Belli, ML | 1 |
| Fenu, ML | 1 |
| Romano, L | 1 |
| Cruciani, M | 1 |
| Solanki, KK | 3 |
| Das, SS | 3 |
| Britton, KE | 5 |
| Malamitsi, J | 1 |
| Giamarellou, H | 1 |
| Kanellakopoulou, K | 1 |
| Dounis, E | 1 |
| Grecka, V | 1 |
| Christakopoulos, J | 1 |
| Koratzanis, G | 1 |
| Antoniadou, A | 1 |
| Panoutsopoulos, G | 1 |
| Batsakis, C | 1 |
| Proukakis, C | 1 |
| Cinquina, AL | 1 |
| Roberti, P | 1 |
| Giannetti, L | 1 |
| Longo, F | 1 |
| Draisci, R | 1 |
| Fagiolo, A | 1 |
| Brizioli, NR | 1 |
| Horcajada, JP | 1 |
| Vilana, R | 1 |
| Moreno-Martínez, A | 1 |
| Alvarez-Vijande, R | 1 |
| Bru, C | 1 |
| Bargalló, X | 1 |
| Buñesch, L | 1 |
| Martínez, JA | 1 |
| Sarda, L | 1 |
| Crémieux, AC | 1 |
| Lebellec, Y | 1 |
| Meulemans, A | 2 |
| Lebtahi, R | 1 |
| Hayem, G | 1 |
| Génin, R | 1 |
| Delahaye, N | 1 |
| Huten, D | 1 |
| Le Guludec, D | 2 |
| Bodur, H | 1 |
| Balaban, N | 1 |
| Aksaray, S | 1 |
| Yetener, V | 1 |
| Akinci, E | 1 |
| Colpan, A | 1 |
| Erbay, A | 1 |
| Larikka, MJ | 2 |
| Ahonen, AK | 2 |
| Niemelä, O | 2 |
| Junila, JA | 2 |
| Hämäläinen, MM | 2 |
| Syrjälä, HP | 2 |
| Rhomberg, PR | 1 |
| Jones, RN | 5 |
| Payen, S | 1 |
| Serreau, R | 1 |
| Munck, A | 1 |
| Aujard, Y | 1 |
| Aigrain, Y | 1 |
| Bressolle, F | 1 |
| Derevianko, II | 1 |
| Putnam, SD | 1 |
| Frenck, RW | 1 |
| Riddle, MS | 1 |
| El-Gendy, A | 1 |
| Taha, NN | 1 |
| Pittner, BT | 1 |
| Abu-Elyazeed, R | 1 |
| Wierzba, TF | 1 |
| Rao, MR | 1 |
| Savarino, SJ | 1 |
| Clemens, JD | 1 |
| Schultz, CH | 1 |
| Fine, AM | 1 |
| Wong, JB | 1 |
| Fraser, HS | 1 |
| Fleisher, GR | 1 |
| Mandl, KD | 1 |
| Artiko, V | 2 |
| Obradović, V | 2 |
| Davidović, B | 2 |
| Petrović, M | 1 |
| Nikolić, N | 2 |
| Petrović, N | 2 |
| Vlajković, M | 1 |
| Matić, S | 1 |
| Kecmanović, D | 1 |
| Bosnjaković, V | 2 |
| Milovanović, V | 1 |
| Ngan, CC | 1 |
| Lim, T | 1 |
| Choo, CM | 1 |
| Toh, GL | 1 |
| Lim, YS | 1 |
| Idowu, OR | 1 |
| Peggins, JO | 1 |
| Albayrak, F | 1 |
| Cokca, F | 1 |
| Erdem, B | 2 |
| Aysev, AD | 1 |
| Sunderland, J | 1 |
| Lovering, AM | 1 |
| Tobin, CM | 1 |
| MacGowan, AP | 1 |
| Roe, JM | 1 |
| Delsol, AA | 1 |
| De Winter, F | 1 |
| Gemmel, F | 1 |
| Van Laere, K | 1 |
| De Winter, O | 1 |
| Poffijn, B | 1 |
| Dierckx, RA | 1 |
| Van de Wiele, C | 1 |
| Rupali, P | 1 |
| Abraham, OC | 1 |
| Jesudason, MV | 1 |
| John, TJ | 1 |
| Zachariah, A | 1 |
| Sivaram, S | 1 |
| Mathai, D | 1 |
| Zelenitsky, SA | 1 |
| Iacovides, H | 1 |
| Harding, GK | 1 |
| Ariano, RE | 1 |
| Schito, AM | 1 |
| Schito, GC | 1 |
| López-Merino, A | 1 |
| Contreras-Rodríguez, A | 1 |
| Migranas-Ortiz, R | 1 |
| Orrantia-Gradín, R | 1 |
| Hernández-Oliva, GM | 1 |
| Gutiérrez-Rubio, AT | 1 |
| Cardeñosa, O | 1 |
| Michalska, K | 1 |
| Pajchel, G | 1 |
| Tyski, S | 1 |
| Zhou, W | 1 |
| Du, W | 2 |
| Cao, H | 1 |
| Zhao, J | 1 |
| Yang, S | 1 |
| Li, W | 1 |
| Shen, Y | 1 |
| Zhang, S | 2 |
| Zhang, X | 1 |
| Langer, O | 1 |
| Brunner, M | 1 |
| Zeitlinger, M | 1 |
| Ziegler, S | 1 |
| Müller, U | 1 |
| Dobrozemsky, G | 1 |
| Lackner, E | 1 |
| Joukhadar, C | 1 |
| Mitterhauser, M | 1 |
| Wadsak, W | 1 |
| Minar, E | 1 |
| Dudczak, R | 1 |
| Kletter, K | 1 |
| Müller, M | 1 |
| Kirbis, A | 1 |
| Marinsek, J | 1 |
| Flajs, VC | 1 |
| Sulochana, S | 1 |
| Rahman, F | 1 |
| Paramasivan, CN | 1 |
| Espinosa-Mansilla, A | 2 |
| Peña, AM | 1 |
| Gómez, DG | 1 |
| Salinas, F | 1 |
| Singh, B | 2 |
| Mittal, BR | 2 |
| Bhattacharya, A | 1 |
| Aggarwal, A | 1 |
| Nagi, ON | 1 |
| Singh, AK | 2 |
| Miao, Y | 1 |
| Hou, F | 1 |
| Jiang, C | 1 |
| Muñoz de la Peña, A | 1 |
| Cañada-Cañada, F | 1 |
| González Gómez, D | 1 |
| Vucetić, C | 1 |
| Lesić, A | 1 |
| Sudjić, V | 1 |
| Marinković, V | 1 |
| Alexander, K | 1 |
| Drost, WT | 1 |
| Mattoon, JS | 1 |
| Kowalski, JJ | 1 |
| Funk, JA | 1 |
| Crabtree, AC | 1 |
| Sun, HW | 1 |
| Li, LQ | 1 |
| Chen, XY | 1 |
| Bujalance, C | 1 |
| Jiménez-Valera, M | 1 |
| Moreno, E | 1 |
| Ruiz-Bravo, A | 1 |
| Ercis, S | 1 |
| Hasçelik, G | 1 |
| Gür, D | 1 |
| Johnson, G | 1 |
| Millar, MR | 1 |
| Matthews, S | 1 |
| Skyrme, M | 1 |
| Marsh, P | 1 |
| Barringer, E | 1 |
| O'Hara, S | 1 |
| Wilks, M | 1 |
| Dutta, P | 1 |
| Bhansali, A | 1 |
| Masoodi, SR | 1 |
| Sofikerim, M | 1 |
| Gülmez, I | 1 |
| Karacagil, M | 1 |
| Sjöstrand, A | 1 |
| Akhras, M | 1 |
| Gharizadeh, B | 1 |
| Lindbäck, E | 1 |
| Pourmand, N | 1 |
| Wretlind, B | 1 |
| Fredlund, H | 1 |
| Sharma, R | 1 |
| Tewari, KN | 1 |
| Bhatnagar, A | 1 |
| Mondal, A | 1 |
| Mishra, AK | 1 |
| Chopra, MK | 1 |
| Rawat, H | 1 |
| Kashyap, R | 1 |
| Tripathi, RP | 1 |
| Wang, Z | 1 |
| Zhu, Y | 1 |
| Ding, S | 1 |
| He, F | 1 |
| Beier, RC | 1 |
| Li, J | 1 |
| Jiang, H | 1 |
| Feng, C | 1 |
| Wan, Y | 1 |
| Kai, Z | 1 |
| Yang, X | 1 |
| Shen, J | 1 |
| Scotti da Silva-Colombeli, A | 1 |
| Falkenberg, M | 1 |
| Choe, YM | 1 |
| Choe, W | 1 |
| Lee, KY | 1 |
| Ahn, SI | 1 |
| Kim, K | 1 |
| Cho, YU | 1 |
| Choi, SK | 1 |
| Hur, YS | 1 |
| Kim, SJ | 1 |
| Hong, KC | 1 |
| Shin, SH | 1 |
| Kim, KR | 1 |
| Woo, ZH | 1 |
| Bennett, KM | 1 |
| Scarborough, JE | 1 |
| Sharpe, M | 1 |
| Dodds-Ashley, E | 1 |
| Kaye, KS | 1 |
| Hayward, TZ | 1 |
| Vaslef, SN | 1 |
| Cho, HJ | 1 |
| Goudah, A | 1 |
| Sung, GM | 1 |
| Yi, H | 1 |
| Seo, DC | 1 |
| Kim, JS | 1 |
| Jeong, JY | 1 |
| Lee, SH | 1 |
| Shin, HC | 1 |
| Liu, L | 1 |
| Pang, X | 1 |
| Zhang, D | 1 |
| Xu, X | 1 |
| Liu, H | 1 |
| Liang, Y | 1 |
| Xie, L | 1 |
| Liu, X | 1 |
| Welling, M | 1 |
| Stokkel, M | 1 |
| Balter, J | 1 |
| Sarda-Mantel, L | 1 |
| Marchesini, GR | 1 |
| Buijs, J | 1 |
| Haasnoot, W | 1 |
| Hooijerink, D | 1 |
| Jansson, O | 1 |
| Nielen, MW | 1 |
| Johnson, DM | 1 |
| van Tiel, FH | 1 |
| Slangen, BF | 1 |
| Schouten, HC | 1 |
| Jacobs, JA | 1 |
| Ketley, NJ | 1 |
| Kelsey, SM | 1 |
| Newland, AC | 1 |
| Stevens, JP | 1 |
| Daniel, TM | 1 |
| Pei, YY | 1 |
| Meng, X | 1 |
| Nightingale, CH | 1 |
| Engel, LS | 1 |
| Callegan, MC | 1 |
| Hill, JM | 1 |
| O'Callaghan, RJ | 1 |
| Rams, TE | 1 |
| Feik, D | 1 |
| Slots, J | 1 |
| Davis, JD | 1 |
| Aarons, L | 1 |
| Houston, JB | 1 |
| Vinjamuri, S | 3 |
| Hall, AV | 3 |
| Bomanji, J | 2 |
| Siraj, Q | 1 |
| O'Shaughnessy, E | 1 |
| Aramayona, JJ | 2 |
| Mora, J | 1 |
| Fraile, LJ | 1 |
| García, MA | 2 |
| Abadía, AR | 1 |
| Bregante, MA | 2 |
| Cogollos, R | 1 |
| Alós, JI | 1 |
| Gómez-Garcés, JL | 1 |
| Lora-Tamayo, C | 1 |
| Tena, T | 1 |
| Rodriguez, A | 1 |
| Doern, GV | 1 |
| Torres, BB | 1 |
| Jankins, M | 1 |
| Biedenbach, DJ | 1 |
| Durrani, AB | 1 |
| Rab, SM | 1 |
| Solanki, K | 2 |
| Siraj, QH | 1 |
| Das, S | 1 |
| Davies, S | 1 |
| Zadik, PM | 1 |
| Veiopoulou, CJ | 1 |
| Ioannou, PC | 1 |
| Lianidou, ES | 1 |
| Visalli, MA | 1 |
| Jacobs, MR | 1 |
| Appelbaum, PC | 1 |
| Barrett, MS | 1 |
| Deguchi, T | 1 |
| Kamberi, M | 2 |
| Tsutsumi, K | 1 |
| Kotegawa, T | 1 |
| Nakamura, K | 2 |
| Nakano, S | 2 |
| Ba, BB | 1 |
| Ducint, D | 1 |
| Fourtillan, M | 1 |
| Saux, MC | 1 |
| Cohen, E | 1 |
| Maxwell, RJ | 1 |
| Donoghue, DJ | 1 |
| Zupancic, T | 1 |
| Pihlar, B | 1 |
| Manceau, J | 1 |
| Gicquel, M | 1 |
| Laurentie, M | 1 |
| Sanders, P | 1 |
| Hajime, N | 1 |
| Kamberi, P | 1 |
| Uemura, N | 1 |
| Solans, C | 1 |
| Rueda, S | 1 |
| Semeniuk, S | 1 |
| Ellis, R | 1 |
| Trautmann, M | 1 |
| Heinemann, M | 1 |
| Möricke, A | 1 |
| Seidelmann, M | 1 |
| Lorenz, I | 1 |
| Berger, D | 1 |
| Steinbach, G | 1 |
| Schneider, M | 1 |
| Nielsen, K | 1 |
| Bangsborg, JM | 1 |
| Høiby, N | 1 |
| Soetebeer, UB | 1 |
| Schierenberg, MO | 1 |
| Möller, JG | 1 |
| Schulz, H | 1 |
| Grünefeld, G | 1 |
| Andresen, P | 1 |
| Ahr, G | 1 |
| Gmuender, H | 1 |
| Kuratli, K | 1 |
| Gray, CP | 1 |
| Keck, W | 1 |
| Evers, S | 1 |
| Segers, B | 1 |
| Olamazadeh, S | 1 |
| Thirion, M | 1 |
| Lambert, J | 1 |
| Sundram, FX | 1 |
| Wong, WY | 1 |
| Ang, ES | 1 |
| Goh, AS | 1 |
| Ng, DC | 1 |
| Yu, S | 1 |
| Khilnani, G | 1 |
| Gupta, RC | 1 |
| Sonmezoglu, K | 1 |
| Sonmezoglu, M | 1 |
| Halac, M | 1 |
| Akgün, I | 1 |
| Türkmen, C | 1 |
| Onsel, C | 1 |
| Kanmaz, B | 1 |
| Uslu, I | 1 |
| Novakovic, J | 1 |
| Nesmerak, K | 1 |
| Nova, H | 1 |
| Filka, K | 1 |
| Vishwanathan, K | 1 |
| Bartlett, MG | 1 |
| Stewart, JT | 1 |
| Yapar, Z | 1 |
| Kibar, M | 1 |
| Yapar, AF | 1 |
| Toğrul, E | 1 |
| Kayaselçuk, U | 1 |
| Sarpel, Y | 1 |
| Presterl, E | 1 |
| Mueller-Uri, P | 1 |
| Grisold, A | 1 |
| Georgopoulos, A | 1 |
| Graninger, W | 1 |
| Lindler, LE | 1 |
| Fan, W | 1 |
| Jahan, N | 1 |
| Schumacher, H | 1 |
| Hoffmann, S | 1 |
| Holmboe, C | 1 |
| Møller, JK | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Presi, S | 1 |
| Furlan, F | 1 |
| Lora, L | 1 |
| Benedetti, P | 1 |
| Bonato, M | 1 |
| Erle, G | 1 |
| de Lalla, F | 1 |
| Mehta, G | 1 |
| Randhawa, VS | 1 |
| Mohapatra, NP | 1 |
| Bailac, S | 1 |
| Ryan, BM | 1 |
| Mazzucco, CE | 1 |
| Lawrence, LE | 1 |
| Ho, H | 1 |
| Warr, G | 1 |
| Barrett, JF | 1 |
| Frosco, M | 1 |
| Dumarey, N | 1 |
| Blocklet, D | 1 |
| Appelboom, T | 1 |
| Tant, L | 1 |
| Schoutens, A | 1 |
| Yew, WW | 1 |
| Chau, CH | 1 |
| Hernández, M | 1 |
| Aguilar, C | 1 |
| Borrull, F | 1 |
| Calull, M | 1 |
| Britton, K | 1 |
| Nagaralli, BS | 1 |
| Seetharamappa, J | 1 |
| Melwanki, MB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Preventive Urinary Tract Infection Role of One Week Solutions of Antimicrobial Application Before Minimally Invasive Upper Tract Lithotomy[NCT02789579] | Early Phase 1 | 150 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ciprofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
Nuclear medicine and the infected joint replacement.
Topics: Arthroplasty, Replacement; Bone and Bones; Bone Marrow; Ciprofloxacin; Fluorodeoxyglucose F18; Human | 2009 |
Topical and systemic treatment for chronic suppurative otitis media.
Topics: Administration, Oral; Administration, Topical; Child; Child, Preschool; Chronic Disease; Ciprofloxac | 2002 |
[Diagnosis and antibiotic treatment of reactive arthritis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Arthritis, Reactive; A | 2002 |
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Italy; Levofloxacin; Micro | 2004 |
12 trials available for ciprofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Basophil Degranulation Test; Ciproflo | 2011 |
Usefulness of 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections.
Topics: Aged; Arthroplasty; Ciprofloxacin; Female; Humans; Joint Diseases; Male; Organotechnetium Compounds; | 2011 |
Infecton: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Citrates; Diphosphonates; Female; | 2003 |
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
Topics: Adult; Aged; Arthritis, Infectious; Bone Diseases; Ciprofloxacin; Diagnosis, Differential; False Pos | 2003 |
99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Female; Humans; Male; Middle Aged; Organotechnetium Compound | 2004 |
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET.
Topics: Aged; Bacterial Infections; Ciprofloxacin; Escherichia coli; Female; Fluorine Radioisotopes; Humans; | 2005 |
Evaluation of the efficacy of 99mTc-Infecton, a novel agent for detecting sites of infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Bacterial Infections; C | 1998 |
Evaluation of technetium-99m ciprofloxacin (Infecton) in the imaging of infection.
Topics: Abscess; Adult; Aged; Bacterial Infections; Ciprofloxacin; Evaluation Studies as Topic; Female; Huma | 2000 |
The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging.
Topics: Arthritis, Infectious; Bone and Bones; Ciprofloxacin; Female; Femur; Gallium Radioisotopes; Hip Join | 2001 |
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.
Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Dru | 2001 |
Infecton is not specific for bacterial osteo-articular infective pathology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Child; Child, Preschool; Ciproflo | 2002 |
Comparison of 99mTc ciprofloxacin, 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Ciprofloxacin; False Positive | 2002 |
144 other studies available for ciprofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
Validity of caregivers' reports on prior use of antibacterials in children under five years presenting to health facilities in Gulu, northern Uganda.
Topics: Adult; Anti-Bacterial Agents; Caregivers; Child, Preschool; Chromatography, Liquid; Ciprofloxacin; C | 2021 |
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Culture Media; Ethiopia; Extensively Drug-R | 2020 |
Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Prescriptions; Drug Resistance, Bacter | 2020 |
Simultaneous HPLC Assay of Gliclazide and Ciprofloxacin in Plasma and its Implementation for Pharmacokinetic Study in Rats.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Gliclazide; Linear Mod | 2021 |
Validation of a procedure to quantify oxolinic acid, danofloxacin, ciprofloxacin and enrofloxacin in selected meats by micellar liquid chromatography according to EU Commission Decision 2002/657/EC.
Topics: Animals; Anti-Bacterial Agents; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug | 2017 |
Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Primers; Gonorrhea; Humans; Microbial Sensitiv | 2017 |
Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial | 2017 |
A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Dru | 2018 |
Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Data Accuracy; Disk Diffusion Antimicrobial Tests; Gonorrhea; | 2018 |
Development of a new liquid chromatographic method for the simultaneous separation of ciprofloxacin degradation products with 5-hydroxymethyl-furfural, impurity of D-glucose, in an intravenous solution for perfusion.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Contamination; Fura | 2019 |
Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Female; Genotype; Geno | 2019 |
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance | 2013 |
Semiautomated solid-phase extraction manifold with a solvent-level sensor.
Topics: Animals; Anti-Bacterial Agents; Automation, Laboratory; Calibration; Ciprofloxacin; Enrofloxacin; Fl | 2013 |
Completely green synthesis of dextrose reduced silver nanoparticles, its antimicrobial and sensing properties.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Escherichia coli; Gelatin; Gluco | 2014 |
Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Linear Models; Male; M | 2016 |
Molecular Assay for Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae Isolates from Cultures and Clinical Nucleic Acid Amplification Test Specimens.
Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Cross Reactions; DNA Gyrase; DNA Topoisomerase IV; Dru | 2015 |
Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.
Topics: Anti-Bacterial Agents; Chromosomes, Bacterial; Ciprofloxacin; DNA Fragmentation; Drug Resistance, Ba | 2016 |
Offline solid-phase extraction for preconcentration of pharmaceuticals and personal care products in environmental water and their simultaneous determination using the reversed phase high-performance liquid chromatography method.
Topics: Acetaminophen; Benzophenones; Caffeine; Carbanilides; Chromatography, High Pressure Liquid; Chromato | 2016 |
Development and application of a capillary electrophoresis-electrochemiluminescent method for the analysis of enrofloxacin and its metabolite ciprofloxacin in milk.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Electrochemistry; Electrophoresis, Capillary; Enroflo | 2008 |
Analysis of ciprofloxacin by a simple high-performance liquid chromatography method.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Pharmaceutical Preparations; Reproducibility of Result | 2008 |
Comparison of solid-phase sorbents for the determination of fluoroquinolone antibiotics in wastewater.
Topics: Adsorption; Anti-Bacterial Agents; Cation Exchange Resins; Chromatography, High Pressure Liquid; Cip | 2008 |
Determination of enrofloxacin and ciprofloxacin in milk using molecularly imprinted solid-phase extraction.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Methac | 2008 |
Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection.
Topics: Anti-Infective Agents; Ciprofloxacin; Electrophoresis, Capillary; Humans; Luminescent Measurements; | 2008 |
Simple assay for monitoring seven quinolone antibacterials in eggs: extraction with hot water and liquid chromatography coupled to tandem mass spectrometry. Laboratory validation in line with the European Union Commission Decision 657/2002/EC.
Topics: Animals; Anti-Bacterial Agents; Calibration; Chickens; Chromatography, Liquid; Ciprofloxacin; Drug R | 2009 |
Global sensitivity analysis for model-based prediction of oxidative micropollutant transformation during drinking water treatment.
Topics: Bezafibrate; Carcinogens; Ciprofloxacin; Methyl Ethers; Naphthols; Ozone; Predictive Value of Tests; | 2009 |
Estimation of 99mTc-ciprofloxacin accumulation indexes in bone and joint bacterial infections.
Topics: Arthritis, Infectious; Bacterial Infections; Bone and Bones; Bone Diseases, Infectious; Ciprofloxaci | 2009 |
Quantitation and identity confirmation of residues of quinolones in tilapia fillets by LC-ESI-MS-MS QToF.
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Food Analysis; Oxoli | 2009 |
Rapid and simple determination of ciprofloxacin resistance in clinical strains of Escherichia coli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Fragmentation; DNA, Bacterial; Drug Resistance, Bacterial; | 2009 |
Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Humans; Least | 2010 |
Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Carrier State; Ciprofloxacin; Disease Outbreak | 2010 |
Bufferized solvent extraction and HPLC fluorometric detection method for sarafloxacin in pig and chicken muscles.
Topics: Acetonitriles; Animals; Buffers; Chemical Fractionation; Chickens; Chromatography, High Pressure Liq | 2011 |
Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma.
Topics: Anti-Infective Agents; Chromatography, Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Huma | 2011 |
Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: an adapted method for neonates.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Drug Stability; Humans; Linear | 2011 |
Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition.
Topics: Child; Child Nutrition Disorders; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stabilit | 2011 |
Comparison of different sample treatments for the analysis of quinolones in milk by capillary-liquid chromatography with laser induced fluorescence detection.
Topics: Animals; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoroquinolones; Lasers; Linear Mode | 2011 |
Validated spectrophotometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Metronidazole; Pharmaceutical Preparations; | 2011 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Iso | 2012 |
Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Hospit | 2012 |
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Ciprofloxacin; Color; Drug Resistance, Multiple, Bacterial; Estonia; Extensiv | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensi | 2012 |
Investigation into the experimental protocols required to determine maximum residue limits (MRLs) in honey.
Topics: Animals; Anti-Infective Agents; Bees; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Honey; S | 2012 |
Antibiotic resistance in urinary tract infections in college students.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary | 2012 |
Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Carrier State; Ciproflox | 2013 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Cipr | 2013 |
Use of a LightCycler gyrA mutation assay for identification of ciprofloxacin-resistant Campylobacter coli.
Topics: Animals; Anti-Infective Agents; Base Sequence; Campylobacter coli; Ciprofloxacin; DNA Gyrase; Drug R | 2002 |
Determination of residues of enrofloxacin and its metabolite ciprofloxacin in chicken muscle by capillary electrophoresis using laser-induced fluorescence detection.
Topics: Animals; Anti-Infective Agents; Calibration; Chickens; Ciprofloxacin; Electrophoresis, Capillary; En | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gent | 2002 |
Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Levofloxacin; M | 2002 |
Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Dose-Response Relationship, Drug; | 2002 |
Liquid chromatography analysis of enrofloxacin and ciprofloxacin in chicken blood spotted on filter-paper disks.
Topics: Animals; Anti-Infective Agents; Chickens; Chromatography, Liquid; Ciprofloxacin; Enrofloxacin; Fluor | 2002 |
Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction.
Topics: Anti-Infective Agents; Chemistry Techniques, Analytical; Chemistry, Physical; Ciprofloxacin; Humans; | 2002 |
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Gram-Neg | 2002 |
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
Topics: Bacteriological Techniques; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Chi-Square D | 2003 |
Infection is not specific for bacterial osteo-articular infective pathology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Child; Child, Preschool; Ciproflo | 2003 |
Determination of enrofloxacin and its metabolite ciprofloxacin in goat milk by high-performance liquid chromatography with diode-array detection. Optimization and validation.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; F | 2003 |
Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Ceftriaxone; Ciprofloxacin; | 2003 |
Biotypes and antimicrobial susceptibilities of Brucella isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Brucella melitensis; Brucellosis; Ceftriaxone; C | 2003 |
Specificity of 99mTc-ciprofloxacin imaging.
Topics: Bacterial Infections; Candidiasis; Ciprofloxacin; Humans; Organotechnetium Compounds; Radionuclide I | 2003 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacteria | 2003 |
Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bayes Theorem; Body Weight; Child; Child, Pr | 2003 |
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; D | 2003 |
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jej | 2003 |
Chinese curses, anthrax, and the risk of bioterrorism.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Decision Support Techniques; | 2004 |
Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Decision Support Techniques; | 2004 |
[Detection of abdominal infections using radio-labeled antibiotics].
Topics: Abdomen; Abdominal Abscess; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; Radi | 2003 |
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clindamycin; Drug Resistance, Mul | 2004 |
Simple, rapid determination of enrofloxacin and ciprofloxacin in bovine milk and plasma by high-performance liquid chromatography with fluorescence detection.
Topics: Animals; Calibration; Cattle; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; Flu | 2004 |
Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivi | 2004 |
A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; F | 2004 |
Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.
Topics: Adolescent; Adult; Child; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; | 2004 |
Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
Topics: Ceftazidime; Ciprofloxacin; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Admin | 2004 |
Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
Topics: Anti-Bacterial Agents; Aza Compounds; Brucella; Brucellosis; Ciprofloxacin; Drug Resistance, Multipl | 2004 |
Determination of ciprofloxacin and its impurities by capillary zone electrophoresis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Electrophoresis, Capillary; Reproducibility of Results; Sensit | 2004 |
Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
Topics: Anti-Infective Agents; China; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bact | 2004 |
Introduction of the HPLC method for the determination of quinolone residues in various muscle tissues.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Enrofloxacin; F | 2005 |
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Topics: Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Mi | 2005 |
HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Io | 2005 |
Technetium-99m ciprofloxacin imaging in the diagnosis of postsurgical bony infection and evaluation of the response to antibiotic therapy: A case report.
Topics: Adult; Anti-Bacterial Agents; Bone Screws; Ciprofloxacin; Device Removal; Follow-Up Studies; Fractur | 2005 |
Determination of heparin using ciprofloxacin-Tb3+ as a fluorescence probe.
Topics: Ciprofloxacin; Fluorescent Dyes; Heparin; Sensitivity and Specificity; Terbium | 2005 |
Determinations of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Analytical; Ciprofloxacin; Diclofenac | 2005 |
[Implementation of the radiolabelled antibiotic in the detection of orthopedic infections].
Topics: Arthritis, Infectious; Bacterial Infections; Bone and Bones; Ciprofloxacin; Humans; Knee Prosthesis; | 2005 |
Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coil.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Hors | 2005 |
Flow-injection enhanced chemiluminescence method for determination of ciprofloxacin in pharmaceutical preparations and biological fluids.
Topics: Antioxidants; Body Fluids; Ciprofloxacin; Flow Injection Analysis; Humans; Luminescent Measurements; | 2006 |
A selective differential medium for Lactobacillus plantarum.
Topics: Animals; Bacteriological Techniques; Ciprofloxacin; Colony Count, Microbial; Culture Media; Drug Res | 2006 |
Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; | 2006 |
Evaluation of BacLite Rapid MRSA, a rapid culture based screening test for the detection of ciprofloxacin and methicillin resistant S. aureus (MRSA) from screening swabs.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carrier State; Ciprofloxacin; False Negative Reac | 2006 |
Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot.
Topics: Adult; Aged; Ciprofloxacin; Diabetic Foot; Escherichia coli; Humans; Middle Aged; Organotechnetium C | 2006 |
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Nephrostomy, Percutaneous; Preoperative Care; Sensitiv | 2007 |
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain.
Topics: Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Mandatory Reporting; Microbial Sensiti | 2007 |
Tc-99m ciprofloxacin scans for detection of tubercular bone infection.
Topics: Adolescent; Adult; Bone Diseases; Ciprofloxacin; Diagnosis, Differential; False Positive Reactions; | 2007 |
Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibody Specificity; Ciprofloxacin; Enroflo | 2007 |
Analytical interferences of drugs in the chemical examination of urinary protein.
Topics: Chloroquine; Ciprofloxacin; Clinical Laboratory Techniques; Humans; Pharmaceutical Preparations; Pro | 2007 |
Tc-99m ciprofloxacin imaging in acute cholecystitis.
Topics: Acute Disease; Adult; Aged; Cholecystitis; Ciprofloxacin; Female; Humans; Male; Middle Aged; Organot | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infectio | 2007 |
Monitoring of fluoroquinolone residual levels in chicken eggs by microbiological assay and confirmation by liquid chromatography.
Topics: Animals; Anti-Bacterial Agents; Biological Assay; Calibration; Chemical Fractionation; Chickens; Chr | 2008 |
Determination of caderofloxacin lactate in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Fasting; | 2007 |
The many roads to infection imaging.
Topics: Ciprofloxacin; Communicable Diseases; Diagnostic Imaging; Humans; Molecular Probe Techniques; Sensit | 2008 |
Nanoscale affinity chip interface for coupling inhibition SPR immunosensor screening with Nano-LC TOF MS.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies; Breast; Chickens; Chromatography, Liquid; Ciproflo | 2008 |
Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23-6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Fluoroquinolones; Micr | 1995 |
Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; Colony Count, Microbial; Cross Infection; Dr | 1995 |
Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Bacterial Infections; Catheterization, Cen | 1995 |
Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis.
Topics: Adult; Ciprofloxacin; Decision Support Techniques; Decision Trees; Health Personnel; HIV Seronegativ | 1995 |
An improved HPLC assay for ciprofloxacin in biological samples.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Rabbits; Sensitivity and Speci | 1994 |
Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor.
Topics: Animals; Aqueous Humor; Biological Assay; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivit | 1993 |
Campylobacter rectus in human periodontitis.
Topics: Adolescent; Adult; Age Distribution; Aged; Campylobacter; Chi-Square Distribution; Ciprofloxacin; Cr | 1993 |
Simultaneous assay of fluoroquinolones and theophylline in plasma by high-performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Male; Norfloxacin; Rats; Rat | 1993 |
Comparison of 99mTc infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Humans; Indium Radi | 1996 |
Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxaci | 1996 |
[The E test and quinolone-resistant Campylobacter jejuni].
Topics: Agar; Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Drug R | 1995 |
High concentration of ciprofloxacin in urine invalidates EMIT results.
Topics: Anti-Infective Agents; Ciprofloxacin; Enzyme Multiplied Immunoassay Technique; Forensic Medicine; Hu | 1996 |
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System.
Topics: Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Enterobacteriaceae; Humans; Microb | 1996 |
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
Topics: Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Evaluation Studies as Topic; Gon | 1996 |
Changing spectrum of typhoid.
Topics: Adolescent; Adult; Anti-Infective Agents; Bone Marrow Examination; Ceftriaxone; Cephalosporins; Chil | 1996 |
Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ciprofloxac | 1997 |
Comparison of methods for the isolation of methicillin resistant Staphylococcus aureus.
Topics: Bacteriological Techniques; Ciprofloxacin; Culture Media; Methicillin Resistance; Sensitivity and Sp | 1997 |
Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum.
Topics: Anti-Infective Agents; Cetylpyridinium; Ciprofloxacin; Fluorescence; Humans; Hydrogen-Ion Concentrat | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxaci | 1997 |
Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
Topics: Agar; Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Culture Media; Drug Resistan | 1997 |
Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Sensitivity and | 1998 |
Fully automated high-performance liquid chromatography of ciprofloxacin with direct injection of plasma and Mueller-Hinton broth for pharmacokinetic/pharmacodynamic studies.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Culture Media; Humans; Reproducibility of Resul | 1998 |
Automated multi-residue isolation of fluoroquinolone antimicrobials from fortified and incurred chicken liver using on-line microdialysis and high-performance liquid chromatography with programmable fluorescence detection.
Topics: Animals; Anti-Infective Agents; Chickens; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluor | 1999 |
Preconcentration of quinolones by dialysis on-line coupled to high-performance liquid chromatography.
Topics: Cellulose; Chromatography, High Pressure Liquid; Ciprofloxacin; Dialysis; Hydrogen-Ion Concentration | 1999 |
Simultaneous determination of enrofloxacin and ciprofloxacin in animal biological fluids by high-performance liquid chromatography. Application in pharmacokinetic studies in pig and rabbit.
Topics: Animals; Anti-Infective Agents; Body Fluids; Chromatography, High Pressure Liquid; Ciprofloxacin; En | 1999 |
Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Drug | 1999 |
Determination of orbifloxacin in rabbit plasma by high-performance liquid chromatography with fluorescence detection.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluorescence; R | 1999 |
Determination of fluoroquinolone residues in animal tissues by liquid chromatography.
Topics: Animals; Anti-Infective Agents; Cattle; Chromatography, Liquid; Ciprofloxacin; Drug Residues; Fluoro | 1999 |
Endotoxin release due to ciprofloxacin measured by three different methods.
Topics: Anti-Infective Agents; Bacterial Toxins; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Enz | 1999 |
Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Resis | 2000 |
Capillary electrophoresis with laser-induced fluorescence in clinical drug development routine application and future aspects.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Design; Electrophoresis, Capillary; Fluoro | 2000 |
Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.
Topics: Bacterial Proteins; Ciprofloxacin; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Gene Ex | 2001 |
[A new method of scintigraphy].
Topics: Adult; Aged; Aged, 80 and over; Bone Diseases, Infectious; Ciprofloxacin; Female; Humans; Joint Dise | 2000 |
Inadvertent use of ciprofloxacin as a single agent in undiagnosed tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; India; Microbial Sensitivity Tests; Mycobacterium tube | 1998 |
Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Child; Child, Preschool; Chron | 2001 |
An HPTLC method for the determination and the purity control of ciprofloxacin HCl in coated tablets.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Ciprofloxac | 2001 |
Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Gatifl | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxaci | 2001 |
Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Probes; Drug Resistance, Bacter | 2001 |
A procedure for evaluation and documentation of susceptibility test methods using the susceptibility of Klebsiella pneumoniae to ciprofloxacin as a model.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pr | 2001 |
Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India.
Topics: Ciprofloxacin; Humans; India; Microbial Sensitivity Tests; Salmonella typhi; Sensitivity and Specifi | 2001 |
Determination of difloxacin and sarafloxacin in chicken muscle using solid-phase extraction and capillary electrophoresis.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Drug Residues; Electrophoresis, Capillary; | 2002 |
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluor | 2002 |
Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)--a balanced view?
Topics: Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Microbial Sensiti | 2002 |
Determination of ciprofloxacin, enrofloxacin and flumequine in pig plasma samples by capillary isotachophoresis--capillary zone electrophoresis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Electrophoresis, Capillary; Enrofloxacin; Fluoroquino | 2002 |
Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations.
Topics: Amoxicillin; Ciprofloxacin; Pharmaceutical Preparations; Piroxicam; Sensitivity and Specificity; Spe | 2002 |